Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Redox Biology|February 18, 2017
Angiogenesis in the atherosclerotic plaqueCaroline Camaré, Mélanie Pucelle, Anne Nègre-Salvayre, et al.
Free Radical Biology & Medicine|January 2, 2017
Proatherogenic effects of 4-hydroxynonenalAnne Nègre-Salvayre, Sandra Garoby-Salom, Audrey Swiader, et al.
The Journal of Infection|January 20, 2019
Hepatitis E virus genotype 3 and capsid protein in the blood and urine of immunocompromised patientsOlivier Marion, Nicolas Capelli, Sebastien Lhomme, et al.
Redox Biology|January 2, 2015
Elastin aging and lipid oxidation products in human aortaKamelija Zarkovic, Pauline Larroque-Cardoso, Mélanie Pucelle, et al.
Free Radical Biology & Medicine|February 9, 2016
The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDLCaroline Camaré, Nathalie Augé, Mélanie Pucelle, et al.
Viruses|January 30, 2020
Optimized Hepatitis E Virus (HEV) Culture and its Application to Measurements of HEV InfectivityNicolas Capelli, Martine Dubois, Mélanie Pucelle, et al.
Acta Neuropathologica Communications|April 5, 2018
Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer's disease brainGaëlle Dominguez, Marie-Lise Maddelein, Mélanie Pucelle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2009
IRES-based vector coexpressing FGF2 and Cyr61 provides synergistic and safe therapeutics of lower limb ischemiaAudrey Rayssac, Charles Neveu, Mélanie Pucelle, et al.
Oxidative Medicine and Cellular Longevity|May 9, 2017
4-Hydroxynonenal Contributes to Angiogenesis through a Redox-Dependent Sphingolipid Pathway: Prevention by Hydralazine DerivativesCaroline Camaré, Corinne Vanucci-Bacqué, Nathalie Augé, et al.
Journal of Medical Virology|October 8, 2022
Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infectionMarion Migueres, Sabine Chapuy-Regaud, Marcel Miédougé, et al.
Pageof 2